Skip to main content
. 2018 May 24;2(2):103–112. doi: 10.1016/j.mayocpiqo.2018.03.006

Table 2.

Survey Results

Question n (%)
Correctly identified lipid profile
 • Percentage of faculty 155 (92)
 • Percentage of residents and fellows 21 (53)
Number of patients with FH seen by the majority (>50%) of
 • Primary care physicians (n=74) 0-3 (58.2)
 • Cardiologists (n=33) >7 (51.5)
 • Endocrinologists (n=7) >10 (70)
Respondents who believed a CDS tool would be helpful in the management of a patient with FH 205 (98)
Perceived utility of FH order-set
 • Very helpful 76 (37.2)
 • Somewhat helpful 88 (43.1)
 • Neither helpful nor unhelpful 19 (9.3)
 • Somewhat unhelpful 12 (5.8)
 • Very unhelpful 9 (4.4)
Preference for alert location
 • Upon accessing the patient record 42 (20)
 • Upon reviewing the laboratory data 105 (50)
 • No alert, instead highlight the patient on caregiver’s schedule 16 (8)
 • Inbox notification 83 (40)
 • No alert 8 (4)
Elements related to the configuration of CDS tool
 • Reminder to rule out secondary causes of hyperlipidemia 139 (66)
 • Reminder to screen family members 126 (60)
 • Initiate/optimize lipid-lowering therapy 149 (71)
 • Cardiovascular genomics consultation for family pedigree and genetic testing 106 (51)
 • Link to relevant scientific statements 76 (36)
 • Link to AskMayoExpert 138 (65)
Components of order-set
 • Lipid profile 151 (72)
 • Cardiovascular genomics consultation for possible genetic testing and family pedigree 165 (79)
 • Reminder to test family members 137 (65)
 • Other 16 (8)

CDS = clinical decision support; FH = familial hypercholesterolemia.